Skip to content
6-K

Foreign Interim / Material

Achilles Therapeutics plc

0000950170-24-096668

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 40.36M sh
Shares Diluted Q2 2024 · Jun 30, 2024 40.32M sh
Shares Diluted Q2 2024 · Jun 30, 2023 39.9M sh
Shares Diluted Q2 2024 · Jun 30, 2023 39.82M sh
Capex Q2 2024 · Jun 30, 2024 $731K
Capex Q2 2024 · Jun 30, 2023 $991K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$34.81M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$35.26M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $95.11M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $131.54M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $143.71M
Stockholders Equity Q2 2024 · Jun 30, 2024 $115.48M
Stockholders Equity Q2 2024 · Mar 31, 2024 $130.35M
Stockholders Equity Q2 2024 · Dec 31, 2023 $142.37M
Stockholders Equity Q2 2024 · Jun 30, 2023 $173.84M
Stockholders Equity Q2 2024 · Mar 31, 2023 $185.17M
Stockholders Equity Q2 2024 · Dec 31, 2022 $197.04M
Current Liabilities Q2 2024 · Jun 30, 2024 $14.3M
Current Liabilities Q2 2024 · Dec 31, 2023 $17M
Total Liabilities Q2 2024 · Jun 30, 2024 $15.71M
Total Liabilities Q2 2024 · Dec 31, 2023 $19.09M
Current Assets Q2 2024 · Jun 30, 2024 $117.82M
Current Assets Q2 2024 · Dec 31, 2023 $145.63M
Total Assets Q2 2024 · Jun 30, 2024 $131.19M
Total Assets Q2 2024 · Dec 31, 2023 $161.46M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.41
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.71
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.42
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.86
Eps Basic Q2 2024 · Jun 30, 2024 −$0.41
Eps Basic Q2 2024 · Jun 30, 2024 −$0.71
Eps Basic Q2 2024 · Jun 30, 2023 −$0.42
Eps Basic Q2 2024 · Jun 30, 2023 −$0.86
Sga Expense Q2 2024 · Jun 30, 2024 $4.16M
Sga Expense Q2 2024 · Jun 30, 2024 $8.32M
Sga Expense Q2 2024 · Jun 30, 2023 $4.32M
Sga Expense Q2 2024 · Jun 30, 2023 $9M
Rd Expense Q2 2024 · Jun 30, 2024 $13.64M
Rd Expense Q2 2024 · Jun 30, 2024 $23.78M
Rd Expense Q2 2024 · Jun 30, 2023 $13.77M
Rd Expense Q2 2024 · Jun 30, 2023 $27.64M
Net Income Q2 2024 · Jun 30, 2024 −$16.38M
Net Income Q2 2024 · Jun 30, 2024 −$28.65M
Net Income Q2 2024 · Mar 31, 2024 −$12.27M
Net Income Q2 2024 · Jun 30, 2023 −$16.85M
Net Income Q2 2024 · Jun 30, 2023 −$34.35M
Net Income Q2 2024 · Mar 31, 2023 −$17.51M
Operating Income Q2 2024 · Jun 30, 2024 −$17.8M
Operating Income Q2 2024 · Jun 30, 2024 −$32.1M
Operating Income Q2 2024 · Jun 30, 2023 −$18.09M
Operating Income Q2 2024 · Jun 30, 2023 −$36.65M